PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 14555539-9 2003 This down-regulation of PPARgamma mRNA by EGF was blocked in the presence of NS-398, a selective COX-2 inhibitor. N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide 77-83 peroxisome proliferator activated receptor gamma Homo sapiens 24-33 19056168-1 2009 Although inhibition of cyclooxygenase-2 (COX-2) or activation of peroxisome proliferators-activated receptor gamma (PPAR-gamma) leads to growth inhibition in malignancies, the synergistic anti-tumor effects of combination of COX-2 inhibitor (NS-398) and PPAR-gamma agonist (rosiglitazone) on the human pancreatic cancer cells remains unknown. N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide 242-248 peroxisome proliferator activated receptor gamma Homo sapiens 116-126 23943857-6 2013 Celecoxib-elicited PPARgamma translocation was inhibited by NS-398. N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide 60-66 peroxisome proliferator activated receptor gamma Homo sapiens 19-28 12736714-3 2003 Treatment of MDA-MB-231 breast cancer cells with NS-398 (a COX-2 inhibitor) or ciglitazone (CGZ, a PPARgamma-ligand) significantly inhibited cell proliferation and markedly increased apoptotic rates. N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide 49-55 peroxisome proliferator activated receptor gamma Homo sapiens 99-108 11809750-4 2002 The cyclooxygenase-2 inhibitor NS398 blocked PPARgamma-induced PGE(2) secretion. N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide 31-36 peroxisome proliferator activated receptor gamma Homo sapiens 45-54 26863638-8 2016 Fluorescence microscopy analyses revealed a lovastatin-induced cytosol-to-nucleus translocation of PPARgamma that was inhibited by NS-398. N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide 131-137 peroxisome proliferator activated receptor gamma Homo sapiens 99-108